rebel Financial rebel Financial
← All Posts
TECH

Bio-Techne Corporation

September 24, 2026 • Author: Phil Ratcliff • TECH
Item Proposal Vote
1 To approve and adopt the Agreement and Plan of Merger, dated as of June 25, 2026 (as it may be amended from time to time in accordance with its terms, the "Merger Agreement"), byandamong Bio-Techne Corporation ("Bio-Techne"), Merck KGaA, Darmstadt, Germany, and EMD HoldingsNewCo, Inc. ("Merger Sub"), including, for purposes of the Minnesota Business Corporation Act, the plan of merger contained in the Merger Agreement. ✓ For
2 To approve, by a non-binding advisory vote, the compensation that may be paid or become payable to Bio-Techne's named executive officers that is based on, or otherwise relates to, the merger of Merger Sub with and into Bio-Techne, as contemplated by the Merger Agreement. ✓ For
3 To adjourn the special meeting of Bio-Techne shareholders (the "Special Meeting") from time to time to a later date or time, if necessary or appropriate, including to solicit additional proxies in favor of the proposal to approve and adopt the Merger Agreement if there are insufficient votes at the time of the Special Meeting to approve and adopt the Merger Agreement. ✓ For
Attachments
📄
TECH_Proxy_Statement_09152026.pdf 2.3 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.